Agilon Health Stock Fair Value Calculation – Agilon Health Director Makes Significant Investment, Purchasing Over 22K Shares

December 1, 2023

☀️Trending News

Agilon Health ($NYSE:AGL) is a technology-enabled healthcare services company that is revolutionizing the way healthcare providers and payers work together. The director of Agilon Health, has recently made a significant investment in the company, purchasing over 22,000 shares. This move by the director reflects the company’s confidence in its future prospects, as well as its dedication to creating a successful and profitable business. The director’s purchase of over 22,000 shares indicates a strong belief in the long-term success of Agilon Health. This new influx of capital will allow the company to further develop its innovative products and services, helping to increase its market presence and appeal to consumers.

It also demonstrates Agilon Health’s commitment to its shareholders, as it works towards becoming a more prominent player in the healthcare services industry. Going forward, the director’s significant investment in Agilon Health will be an ongoing source of support for the company and its investors. It will help Agilon Health to continue its ambitious growth, while remaining financially sound and providing investors with reliable returns. With this new acquisition, the company has sent a clear message to the marketplace that it is dedicated to long-term success and profitability.

Price History

On Thursday, Agilon Health, a leading provider of healthcare solutions, saw a significant investment in its stock when the company’s director purchased over 22,000 shares. The stock opened at $10.7 and closed at $10.6, representing a 0.7% decrease from its prior closing price. This latest investment comes as part of the company’s ongoing efforts to grow and strengthen its position in the healthcare industry. With the director showing confidence in the company’s prospects, investors may be encouraged to follow suit in the upcoming trading sessions. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Agilon Health. More…

    Total Revenues Net Income Net Margin
    4.19k -88.63 -2.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Agilon Health. More…

    Operations Investing Financing
    -144.99 -49.79 -191.16
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Agilon Health. More…

    Total Assets Total Liabilities Book Value Per Share
    2.28k 1.41k 2.15
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Agilon Health are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    50.5% -1.9%
    FCF Margin ROE ROA
    -4.0% -5.8% -2.2%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Agilon Health Stock Fair Value Calculation

    At GoodWhale, we conducted an analysis of AGILON HEALTH‘s financials to determine a fair value for its stock. After taking various factors into consideration, our proprietary Valuation Line determined a fair value of $42.0 per share. We have found that AGILON HEALTH is currently being traded at $10.6 per share, which represents a significant discount of 74.8%. This indicates that AGILON HEALTH stock is undervalued and may present investors with a great opportunity for long-term gains. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    Its competitors include P3 Health Partners Inc, Oak Street Health Inc, and Pathway Health Corp.

    – P3 Health Partners Inc ($NASDAQ:PIII)

    P3 Health Partners Inc is a US-based healthcare company that provides services and products to health plans, provider groups, and individuals. The company has a market capitalization of 212.47 million as of 2022 and a return on equity of 196.33%. P3 Health Partners Inc is a leading provider of healthcare services and products in the United States. The company offers a wide range of services and products, including health insurance, provider services, and individual products. P3 Health Partners Inc is a publicly traded company listed on the New York Stock Exchange.

    – Oak Street Health Inc ($NYSE:OSH)

    Oak Street Health Inc is a healthcare services company that operates primary care centers for adults on Medicare in the United States. As of December 31, 2020, the company operated 109 primary care centers in Illinois, Indiana, Michigan, New Jersey, Pennsylvania, and Rhode Island. The company was founded in 2013 and is headquartered in Chicago, Illinois.

    – Pathway Health Corp ($TSXV:PHC)

    Pathway Health Corp has a market cap of 4.69M as of 2022, a Return on Equity of -239.69%. The company provides healthcare services to skilled nursing and assisted living facilities.

    Summary

    Agilon Health has recently had an investment surge, with the director of the company revealed as having purchased over 22,000 shares. This has been seen as a vote of confidence in the firm and its future performance. Analysts are expecting Agilon Health to experience significant growth, primarily driven by their experienced leadership team and their ability to stay ahead of the ever-changing healthcare landscape.

    Agilon’s focus on developing innovative and comprehensive healthcare solutions and their commitment to customer service have made them an attractive option for investors. The recent purchase of additional shares is seen as a positive sign that Agilon will continue to be a solid investment choice in the coming years.

    Recent Posts

    Leave a Comment